methods available for blood melatonin include enzyme immunoassay (EIA) [11] , radioimmunoassay (RIA) [12] , GC-MS methods [13, 14] , HPLC with fluorescence detection [15, 16] , and HPLC with electrochemical detection [17] , etc. Although EIA and RIA were very sensitive for the determination of melatonin in blood, some anticoagulants and endogenous interfering compounds may affect their specificity [11, 12] . The other chromatography-based methods [13] [14] [15] 17] require prior sample preparations (e.g. liquid-liquid extraction or solid-phase extraction) to remove serum proteins and interfering compounds, which are usually time-consuming and laborious. In case of GC-MS methods [13, 14] , derivatization of melatonin is needed prior to the analysis.
The purpose of this work is to develop a rapid, sensitive and specific analytical method for the quantitative determination of serum melatonin by ESI -MS -MS with direct sample injection, which employs an on-line sample extraction procedure.
Experimental

Chemicals and solutions
Melatonin (N-acetyl-5-methoxytryptamine) and N-acetyltryptamine (internal standard) were obtained from Sigma (St Louis, MO, USA). Ammonium formate, formic acid, HPLC grade water and acetonitrile were from Aldrich (Milwaukee, WI, USA). Human sera (cat. number S7023, lot number 120K8972) was purchased from Sigma and kept at − 20°C.
A stock solution of ammonium formate (50 mM, pH 4.0) was prepared by dissolving appropriate amounts of ammonium formate in a known volume of HPLC grade water. The pH of the solution was adjusted to the desired value with formic acid. Five mM ammonium formate at pH 4.0 was prepared by 1:10 dilution of the stock solution with HPLC grade water.
Stock solutions (1.00 mg/ml) of melatonin and N-acetyltryptamine (0.500 mg/ml, internal standard) were prepared by dissolving appropriate amounts of each compound in a known volume of methanol, which were stored at − 20°C when not used.
Working standard solutions of melatonin (8.00, 80.0, 600 and 1000 ng/ml) and N-acetyltryptamine (8.00, 80.0, 200 and 600 ng/ml) were prepared by serial dilution of the stock solutions with 5 mM ammonium formate (pH 4.0).
Blank sera, serum standards and samples
Human sera contained no detectable melatonin were used as the blank sera. Serum standards (0.500, 1.00, 2.00, 5.00, 15.0, 50.0, 100 and 200 ng/ml) were prepared by the serial dilution of the 1000-ng/ml melatonin working standard solution with the blank sera.
Prior to the analysis, 10-ml internal standard solution (N-acetyltryptamine, 200 ng/ml in 5 mM ammonium formate at pH 4.0) was added to 200-ml serum standards and serum samples. The mixtures were diluted with 190-ml, 5 mM ammonium formate (pH 4.0). After vortex mixing, these solutions were transferred to autosampler vials for instrument analysis.
Instrumentation
The instrumentation system used for this work consisted of an HP1100 pump (Hewlett-Packard, Palo Alto, CA, USA), an HP1100 autosampler, a stainless steel in-line filter (0.5-mm pore, 0.23-ml dead volume, Upchurch Scientific, Oak Harbor, + at m/z 203) with a span of 0.05 u, a dwell time of 0.5 s, and an inter-scan delay of 0.03 s. Ionization parameters were the same as those described above.
Multiple reaction monitoring (MRM) data were acquired with the following parameters: m/z 233\ 174 for melatonin, m/z 203 \144 for Nacetyltryptamine, argon collision gas at 1.0 mbar, cone at 25 V, collision energy at 15 eV for each analyte, low-and high-mass resolution at 15 for both quadrupole 1 and 3, dwell time of 0.5 s, and inter-scan delay of 0.03 s. The ionization parameters used for MRM were the same as those for SIR.
Quantitation
Data acqusition was done by MICROMASS MASSLYNX software (Version 3.4). The peak area ratios of melatonin to the internal standard (Yaxis values) were plotted against the melatonin concentrations (X-axis values) for the regression equation. The serum melatonin concentration of the unknown sample was determined by the regression equation after obtaining the peak area ratio of the unknown to the internal standard from the mass chromatograms.
Reco6ery
The three-concentration-level (2.00, 20.0 and 150 ng/ml) serum samples used in the recovery studies were prepared by adding 50-ml internal standard (N-acetyltryptamine, at 8.00, 80.0 and 600 ng/ml in 5 mM ammonium formate at pH 4.0), 50-ml melatonin (at 8.00, 80.0 and 600 ng/ml in 5 mM ammonium formate at pH 4.0), and 100-ml of 5 mM ammonium formate (pH 4.0) to 200-ml blank serum. The control samples were prepared in 5 mM ammonium formate (pH 4.0) at the same concentration levels. The recoveries of melatonin and N-acetyltryptamine in human sera were determined by comparing the mean peak areas of serum samples to the mean peak areas of the control samples.
Results and discussions
On-line sample preparation
Sample preparation is the bottleneck of most of drug analyses in biological fluids. Direct sample injection with on-line sample preparation has been developed to simplify and expedite the analytical procedure for drug analyses. In this work, Waters Oasis ® HLB extraction cartridge was used as an on-line column for the extraction of serum melatonin and N-acetyltryptamine (internal standard). According to the manufacturer, the packing material of the extraction column is a macroporous copolymer [poly(divinylbenzene-co-N-vinylpyrrolidone)] and HLB is an acronym for hydrophillic lipophillic balance which describes the dual retention capability of the packing material to retain polar and nonpolar compounds. The water wettable polymeric sorbent of Oasis ® HLB allows the exclusion of proteins and other interfering matrix constituents, and the retention of acids, bases and neutral compounds with high and reproducible recoveries [18] .
By the experiments shown in Fig. 3 , it was found that serum proteins and other interfering matrix constituents were completely eluted in less than 1 min after sample injection using 5 mM ammonium formate (pH 4.0) at the flow rate of 1.0 ml/min as the extraction buffer (Fig. 3A) . Meanwhile, melatonin, N-acetyltryptamine and other endogenous compounds were retained on the column even after 9-min washing with the extraction buffer (Fig. 3B) . Therefore, 2-min after sample injection was chosen as the switching time when the switching valve was turned from the position 1 to 2 (Fig. 2) . The elution of melatonin and N-acetyltryptamine as well as other endogenous compounds took place after the extraction buffer was changed to the elution buffer (95% CH 3 CN + 5% 5 mM ammonium formate at pH 4.0) at 2 min of the sample injection. Fig. 3C and D showed that these compounds reached the UV 
Sodium adducts
Melatonin and N-acetyltryptamine could easily form adducts with sodium ion in the positive electrospray ionization process. The formation of sodium adducts [M+ Na]
+ competed with the formation of quasi-molecular ions [M+ H] + and affected the detection sensitivity. Hence, it should be suppressed. The experiments indicated that ammonium formate was more effective in suppressing the formation of sodium adducts than formic acid; whereas formic acid might cause a low ionization efficiency of the analytes as trifluoroacetic acid (TFA) did in the previous study [19] . For the subsequent studies, 5% 5 mM ammonium formate (pH 4.0) was used with 95% CH 3 CN as the elution buffer for achieving high detection sensitivity.
Analytical performance
The MRM mode was used for quantitation. Its specificity for detecting melatonin and N-acetyltryptamine was illustrated by the representative mass chromatograms in Fig. 7 , which showed no sign of interference from the co-eluting endogenous compounds in the serum matrix.
The recovery studies of melatonin and Nacetyltryptamine were conducted at three-concentration levels (2.00, 20.0 and 150 ng/ml) and the results were summarized in Table 2 . The absolute recoveries of melatonin and N-acetyltryptamine were 68.9-70.5 and 53.2-59.1%, respectively. The recovery data showed good consistency at all levels. It is noted that recoveries of analytes decreased gradually with a sample injection volume greater than 50 ml (data not shown), which were probably due to the loading capacity of the extraction column at given concentration levels. In this work, an injection volume of 10 ml was used for quantitation.
The method developed has excellent intra-and inter-assay precision for melatonin. As shown in Table 3 , The relative standard deviations of melatonin at four-concentrations for the within-day (intra-assay) study ranged 0.8-2.0% (n= 5) and the day-to-day (inter-assay) study ranged 1.5-5.9% (n = 3).
A good linear relationship was found between the peak-area ratios of melatonin to N-acetyltryptamine (the internal standard) versus the concentrations of melatonin ranging 0.500-200 ng/ml. Linear regression analysis indicated that the correlation coefficient (r 2 ) was greater than 0.999, and the regression equation was Y= 0.129 X+ 0.001 with Y as the peak area ratio and X as the concentration of melatonin.
The measured serum melatonin concentrations were found to be in good agreement with the actual concentrations of melatonin prepared by spiking melatonin in human blank sera. The accuracy bias shown in Table 4 ranged from − 0.80 to − 5.9% at the four concentrations evaluated. Table 3 Intra-and inter-assay precision of serum melatonin
Melatonin
Inter-assay Intra-assay (ng/ml) (%CV, n =5) (%CV, n = 3) a Accuracy bias (%) = (measured value−nominal value)/nominal value×100.
The limit of detection defined as the signal-tonoise ratio of 3 was 0.100 ng/ml for serum melatonin (n =3) and the limit of quantitation defined as the lowest detectable analyte concentration which has an accuracy bias of 18% was 0.500 ng/ml for serum melatonin (n=3).
In comparison with the previously reported atomspheric pressure chemical ionization (APCI)-MS-MS method 20 , it is clearly evident that our ESI -MS -MS method for serum melatonin has lower limit of detection and wider linear dynamic range, are capable of handling larger amount of sample and higher flow rates.
Applicability to pharmacokinetic studies
According to Dollins et al. [9] , melatonin doses at 1 mg or greater were needed to generate peak serum melatonin levels that exceeded the normal range of nocturnal melatonin levels in untreated people, which corresponded to peak serum melatonin levels 0.500 ng/ml or higher.
The method developed has a limit of quantitation of 0.500 ng/ml with 10-ml sample injection, which is suitable for the pharmacokinetic study of melatonin at doses greater than 1 mg. It should also be pointed out that the extraction cartridge used in this work has concentration capability, which allows us to injection sample volumes up to 50 ml without sacrificing the analyte recoveries. Therefore, if lower limits of quantitation are desirable, larger sample volumes can be used. Although the method developed has not yet been tested with clinical samples, its applicability to serum melatonin has been demonstrated.
Conclusions
A rapid, simple and sensitive analytical method for the quantitative determination of melatonin in human serum has been developed and validated. It employs on-line sample preparation and ESI-MS -MS detection. Serum samples can be directly injected into the system and be analyzed within 9 min. The method has wide linear dynamic range, low limit of quantitation, high specificity and sensitivity, as well as excellent reproducibility and accuracy. It may be used for the pharmacokinetic study of melatonin in human sera.
